Canaccord raises Strategy stock price target on balance sheet strength

Canaccord raised Strategy (MSTR) price target to $175 from $130 while keeping a Buy rating, citing stronger company-specific and macro factors; the stock is up 32.5% WoW and trades at $122.63, but remains down 64% YoY. The note also highlights balance-sheet support (current ratio 5.39; liquid assets exceeding short-term obligations) and added liquidity via a $1.59B USD cash pool for potential Bitcoin purchases. Other analysts trimmed targets on lower Bitcoin-price assumptions (e.g., Cantor to $186, B.Riley to $155) and cited an $8.32B unrealized fair value loss on Bitcoin holdings at the recent results.

Analysis

MSTR is trading less like a pure Bitcoin proxy and more like a leveraged balance-sheet option on whether the market will keep assigning it a premium to net asset value. With mNAV near parity, the next leg up is not just about BTC price; it depends on sustained access to capital and a renewed belief that the firm can accrete per-share BTC over time. That makes the equity highly reflexive: small changes in spot BTC or financing conditions can cause outsized moves in the common versus the underlying coin.

The preferred recovery matters more than the headline common rally because it reduces the probability of a funding event forcing deleveraging at the wrong time. In the near term, the setup can remain squeeze-prone for days if crypto stays bid and rates remain soft, but over 1-3 months the key risk is that the rally was mostly de-risking/short covering rather than a durable re-rating. If BTC stalls, real yields rise, or the dollar firms, MSTR can give back more than BTC because the market will re-price the stock as a crowded carry trade rather than a compounding treasury story.

The consensus may be overestimating how quickly the acquisition engine re-accelerates. Without a clear premium to NAV, incremental purchases are less powerful, and the equity loses one of its main catalysts. Falsifiers: mNAV breaking back below 1.0x, preferred slipping materially off par, or BTC failing to hold recent breakout levels over the next 2-6 weeks.

Key Decisions for Investors

• Trim MSTR into strength after the recent squeeze; use any rebound toward the low-$130s to reduce exposure, because upside from here likely requires both BTC appreciation and an mNAV re-rating.
• For BTC bulls, prefer IBIT/spot BTC over MSTR for 1-3 month exposure; if you want leverage, keep MSTR as a satellite position only. This avoids paying for the treasury-premium that may not persist.
• Relative-value trade: long IBIT, short MSTR against equal dollar BTC beta for 1-3 months. The trade works if BTC is range-bound and MSTR multiple normalizes; it loses if mNAV expands back above ~1.2x.
• Optionality expression: sell an out-of-the-money MSTR call spread into the recent volatility spike rather than buying calls. The implied move now looks rich versus the probability of immediate fundamental improvement.
• Watchlist trigger: if preferred falls back materially below par or mNAV drops under 1.0x, shift from neutral to bearish on MSTR common; that would signal the funding story is deteriorating again.